SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-032534
Filing Date
2023-09-19
Accepted
2023-09-19 16:17:11
Documents
17
Period of Report
2023-09-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K frtx-20230918.htm   iXBRL 8-K 51563
2 EX-2.1 a202309188kex21.htm EX-2.1 23584
3 EX-3.1 a202309188kex31.htm EX-3.1 107027
4 EX-99.1 a202309188kex991.htm EX-99.1 22442
8 frtx-20230918_g1.jpg GRAPHIC 29102
9 image_0.jpg GRAPHIC 26518
  Complete submission text file 0001628280-23-032534.txt   480024

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT frtx-20230918.xsd EX-101.SCH 1905
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT frtx-20230918_lab.xml EX-101.LAB 26157
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT frtx-20230918_pre.xml EX-101.PRE 13587
11 EXTRACTED XBRL INSTANCE DOCUMENT frtx-20230918_htm.xml XML 2925
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Fresh Tracks Therapeutics, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 231264006
SIC: 2836 Biological Products, (No Diagnostic Substances)